ESG

The pharma giant's acquisition of Excellergy and its first-in-class Exl-111 could revolutionize treatment for millions with severe, debilitating allergies.

Trooly.AI's new platform uses AI agents to conduct 45-minute user interviews, but its 'Empathy Engine' raises new questions about tech and ethics.

From Taiwan to the world, Gogoro's battery swapping network is reshaping urban transport. Can its proven model solve Asia's mobility and pollution woes?

Agenus prepares a crucial update on its BOT+BAL immunotherapy, a potential breakthrough for cancers resistant to current treatments. What will they reveal?

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

A multi-billion dollar tender for Argentina's main trade artery pits a US-backed group against a rival with alleged hidden ties to Chinese state firms.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.

A Texas clinic is combining brain health therapy, facial rejuvenation, and body sculpting in a novel, 'whole person' approach to wellness and recovery.

An Austin-based firm's rapid expansion to 150 partners shows how CE/CME is moving from conference halls to podcasts, apps, and on-demand platforms.

LiveOnNY launches an emotional ad campaign using a classic song to address New York's critical shortage of registered organ donors. But is a song enough?

Magali Daumas joins Transit Technologies as VP of Marketing, tasked with scaling its AI platform and advancing its mission to close the transit equity gap.

A new wave of drug-free hair restoration combines ancient botanicals with FDA-cleared light therapy, challenging the chemical-reliant status quo.

A US firm is bringing embryo screening for chronic diseases to major IVF networks, sparking debate on the future of family planning and genetic health.

With a 100% residency match, BayCare is doubling its medical training program, creating a vital pipeline of physicians to serve a rapidly growing Florida.

A new wave of dentistry is here. MINISH Veneers is training U.S. dentists in a minimally invasive technique that preserves teeth and changes smiles.

A university-born startup has won a major award for its groundbreaking technology that promises a cheaper, more effective way to remove toxic PFAS.

New research shows high food prices are forcing U.S. consumers to cut beef, produce, and dairy, trading nutrition for affordability at the grocery aisle.

Private firm ION Minerals now controls 280,000 acres across Texas and Canada, a bold move to dominate the future EV battery supply chain.

With a massive new credit facility, Aligned is set to aggressively expand its U.S. data centers, racing to meet the insatiable demand for AI and cloud.

Eurofins Viracor's new assay delivers rapid insights into CAR T-cell performance, promising faster, more personalized decisions for cancer patients.